Enviar búsqueda
Cargar
Innovatie in de Sierteelt & het Businessmodel, door Sander de Leeuw, 16 nov 2011
•
1 recomendación
•
267 vistas
KennisKring Amsterdam
Seguir
'Consolidatie in de logistiek'
Leer menos
Leer más
Empresariales
Vista de diapositivas
Denunciar
Compartir
Vista de diapositivas
Denunciar
Compartir
1 de 3
Recomendados
Mystery of the maya collapse
Mystery of the maya collapse
Mystery of the maya collapse
Albania Energy Association
Presentatie Geleyn Meijer, tijdens Catch Up Sessie 24 juni 2011
Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...
Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...
KennisKring Amsterdam
Invited lecture at international exergy conference, Paris June 17th 2011: Exergy to define structure and quality of materials, energy and ecosystems
Exergy on urban scale - Exergy conference Paris
Exergy on urban scale - Exergy conference Paris
wouterleduc
Slide giới thiệu hệ thống "Hỗ trợ dạy và học trực tuyến với tích hợp Android cho di động", bảo vệ tại khoa CNTT, Viện Đại học Mở Hà Nội 17/06/2012
HOU-eLearning - liemqv & minhbt
HOU-eLearning - liemqv & minhbt
Liem Quang
Case study on redundant enterprise energy management system - AVReporter
Case study on redundant enterprise energy management system - AVReporter
Avreporter KONsys
Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents. The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer cells, for the treatment of acute myeloid leukemia and solid tumors. The Company recently completed a $25.8 million round of financing and is using the proceeds to advance its pipeline, including funding Phase II double-blind, placebo controlled trial of CNDO-201 for the treatment of Crohn's Disease scheduled for initiation in early 2012 and a Phase I/II dose escalation and expansion trial of CNDO-109 for the treatment of relapsed Acute Myeloid Leukemia (AML) planned for 2012. Each of these drugs is a novel therapy that has achieved clinical proof-of-concept in indications with unmet medical needs.
Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference
Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference
ProActive Capital Resources Group
я и школа успеха2
я и школа успеха2
Google
Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary
Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary
Jessica Jasso
Recomendados
Mystery of the maya collapse
Mystery of the maya collapse
Mystery of the maya collapse
Albania Energy Association
Presentatie Geleyn Meijer, tijdens Catch Up Sessie 24 juni 2011
Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...
Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...
KennisKring Amsterdam
Invited lecture at international exergy conference, Paris June 17th 2011: Exergy to define structure and quality of materials, energy and ecosystems
Exergy on urban scale - Exergy conference Paris
Exergy on urban scale - Exergy conference Paris
wouterleduc
Slide giới thiệu hệ thống "Hỗ trợ dạy và học trực tuyến với tích hợp Android cho di động", bảo vệ tại khoa CNTT, Viện Đại học Mở Hà Nội 17/06/2012
HOU-eLearning - liemqv & minhbt
HOU-eLearning - liemqv & minhbt
Liem Quang
Case study on redundant enterprise energy management system - AVReporter
Case study on redundant enterprise energy management system - AVReporter
Avreporter KONsys
Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents. The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer cells, for the treatment of acute myeloid leukemia and solid tumors. The Company recently completed a $25.8 million round of financing and is using the proceeds to advance its pipeline, including funding Phase II double-blind, placebo controlled trial of CNDO-201 for the treatment of Crohn's Disease scheduled for initiation in early 2012 and a Phase I/II dose escalation and expansion trial of CNDO-109 for the treatment of relapsed Acute Myeloid Leukemia (AML) planned for 2012. Each of these drugs is a novel therapy that has achieved clinical proof-of-concept in indications with unmet medical needs.
Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference
Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference
ProActive Capital Resources Group
я и школа успеха2
я и школа успеха2
Google
Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary
Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary
Jessica Jasso
Alliance Bernstein
Alliance Bernstein
shaunbarnes
Media
Media
Hartfordsam
Zain Master's Product and Marketing Portfolio
Product portfolio 2013
Product portfolio 2013
Zain Master
Escalfament del planeta
Escalfament del planeta
Institut Quatre Cantons
BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
ProActive Capital Resources Group
Presentation for small businesses talking about social media and digital strategy in their business.
Smallbiz marketing
Smallbiz marketing
Andrew Sims
A talk I delivered at the Scotland Can Do SCALE event in Stirling. Other speakers included Noam Wasserman of Harvard Business School and Bill Aulet of MIT Sloan. This was a 1.5 hour talk covering three areas I'm really passionate about - great teams, building great products, and making customers successful.
Startup Ingredients (Team, Solving a Problem, Customers)
Startup Ingredients (Team, Solving a Problem, Customers)
John Peebles
NeoStem, Inc. (AMEX: NBS; Stock Twits: $NBS) is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January 2011 acquisition of Progenitor Cell Therapy, LLC ("PCT") is central to the Company's strategic mission of capturing the paradigm shift to cell therapy. The acquisition of PCT gives NeoStem not only access to a world class contract manufacturing cell therapy company but provides a platform and expertise around the evaluation, development and regulatory requirements to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics. NeoStem also holds the worldwide exclusive license to VSEL(TM) Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. Headquartered in San Francisco, JMP Securities was founded in January 2000 in response to the consolidation of established independent research boutiques by large commercial banks. Since the mid-1990s nearly 50 regional investment banks—including San Francisco’s Montgomery Securities, Hambrecht & Quist and Robertson Stephens—have been acquired by major financial institutions. Such industry consolidation has pressured a new breed of bulge-bracket investment banks to compete for large market-capitalization clients and has greatly reduced Wall Street’s focus on the middle market. JMP Securities was formed in the mold of its independent, research-driven predecessors as a growth-oriented, entrepreneurial firm dedicated to serving the needs of small and midsized companies and the institutions that invest in them.
Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites
ProActive Capital Resources Group
BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.
BioNeutral Group ($BONU) - June 2011 PowerPoint
BioNeutral Group ($BONU) - June 2011 PowerPoint
ProActive Capital Resources Group
Teknik menghasilkan blog pembelajaran
Teknik menghasilkan blog 1
Teknik menghasilkan blog 1
Roiamah Basri
Fibrocell Science, Inc. (OTCBB:FCSC.ob - News) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
ProActive Capital Resources Group
Slimme Steden 6 ferbruari, deelsessie Open Data
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
KennisKring Amsterdam
Business Intelligence is an everyday tool for managers and engineers to create demand and consumption analysis, cost allocation reports, risk factor calculations,and much more. More information: http://www.konsys-international.com Twitter: http://twitter.com/avreporter/ Facebook: http://www.facebook.com/pages/KONsys-Energy-Management/149458798400618
Business intelligence
Business intelligence
Avreporter KONsys
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
ProActive Capital Resources Group
basic html tag
html help
html help
Pawan Kandpal
A practical guide to how to go about building the ultimate human organisation. Talk delivered during ArabNet in Beirut, March 2016.
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
John Peebles
energy course introduction
Session 1 energy course introduction
Session 1 energy course introduction
Albania Energy Association
Evaluation 3
Evaluation 3
EDPRICE93
Slimme Steden, 6 februari 2013. Deelsessie Onderwijs en ICT
Roel Spits, Poseidon
Roel Spits, Poseidon
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Hans Haveman gemeente Enschede
Hans Haveman gemeente Enschede
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Martijn Kriens Amsterdam Economic Board
Martijn Kriens Amsterdam Economic Board
KennisKring Amsterdam
Más contenido relacionado
Destacado
Alliance Bernstein
Alliance Bernstein
shaunbarnes
Media
Media
Hartfordsam
Zain Master's Product and Marketing Portfolio
Product portfolio 2013
Product portfolio 2013
Zain Master
Escalfament del planeta
Escalfament del planeta
Institut Quatre Cantons
BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
ProActive Capital Resources Group
Presentation for small businesses talking about social media and digital strategy in their business.
Smallbiz marketing
Smallbiz marketing
Andrew Sims
A talk I delivered at the Scotland Can Do SCALE event in Stirling. Other speakers included Noam Wasserman of Harvard Business School and Bill Aulet of MIT Sloan. This was a 1.5 hour talk covering three areas I'm really passionate about - great teams, building great products, and making customers successful.
Startup Ingredients (Team, Solving a Problem, Customers)
Startup Ingredients (Team, Solving a Problem, Customers)
John Peebles
NeoStem, Inc. (AMEX: NBS; Stock Twits: $NBS) is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January 2011 acquisition of Progenitor Cell Therapy, LLC ("PCT") is central to the Company's strategic mission of capturing the paradigm shift to cell therapy. The acquisition of PCT gives NeoStem not only access to a world class contract manufacturing cell therapy company but provides a platform and expertise around the evaluation, development and regulatory requirements to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics. NeoStem also holds the worldwide exclusive license to VSEL(TM) Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. Headquartered in San Francisco, JMP Securities was founded in January 2000 in response to the consolidation of established independent research boutiques by large commercial banks. Since the mid-1990s nearly 50 regional investment banks—including San Francisco’s Montgomery Securities, Hambrecht & Quist and Robertson Stephens—have been acquired by major financial institutions. Such industry consolidation has pressured a new breed of bulge-bracket investment banks to compete for large market-capitalization clients and has greatly reduced Wall Street’s focus on the middle market. JMP Securities was formed in the mold of its independent, research-driven predecessors as a growth-oriented, entrepreneurial firm dedicated to serving the needs of small and midsized companies and the institutions that invest in them.
Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites
ProActive Capital Resources Group
BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.
BioNeutral Group ($BONU) - June 2011 PowerPoint
BioNeutral Group ($BONU) - June 2011 PowerPoint
ProActive Capital Resources Group
Teknik menghasilkan blog pembelajaran
Teknik menghasilkan blog 1
Teknik menghasilkan blog 1
Roiamah Basri
Fibrocell Science, Inc. (OTCBB:FCSC.ob - News) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
ProActive Capital Resources Group
Slimme Steden 6 ferbruari, deelsessie Open Data
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
KennisKring Amsterdam
Business Intelligence is an everyday tool for managers and engineers to create demand and consumption analysis, cost allocation reports, risk factor calculations,and much more. More information: http://www.konsys-international.com Twitter: http://twitter.com/avreporter/ Facebook: http://www.facebook.com/pages/KONsys-Energy-Management/149458798400618
Business intelligence
Business intelligence
Avreporter KONsys
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
ProActive Capital Resources Group
basic html tag
html help
html help
Pawan Kandpal
A practical guide to how to go about building the ultimate human organisation. Talk delivered during ArabNet in Beirut, March 2016.
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
John Peebles
energy course introduction
Session 1 energy course introduction
Session 1 energy course introduction
Albania Energy Association
Evaluation 3
Evaluation 3
EDPRICE93
Destacado
(18)
Alliance Bernstein
Alliance Bernstein
Media
Media
Product portfolio 2013
Product portfolio 2013
Escalfament del planeta
Escalfament del planeta
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
BioNeutral Group (OTCBB: BONU; Twitter $BONU)
Smallbiz marketing
Smallbiz marketing
Startup Ingredients (Team, Solving a Problem, Customers)
Startup Ingredients (Team, Solving a Problem, Customers)
Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites
BioNeutral Group ($BONU) - June 2011 PowerPoint
BioNeutral Group ($BONU) - June 2011 PowerPoint
Teknik menghasilkan blog 1
Teknik menghasilkan blog 1
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK
Business intelligence
Business intelligence
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
html help
html help
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)
Session 1 energy course introduction
Session 1 energy course introduction
Evaluation 3
Evaluation 3
Más de KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie Onderwijs en ICT
Roel Spits, Poseidon
Roel Spits, Poseidon
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Hans Haveman gemeente Enschede
Hans Haveman gemeente Enschede
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie EHealth
Martijn Kriens Amsterdam Economic Board
Martijn Kriens Amsterdam Economic Board
KennisKring Amsterdam
Slimme Steden 6 februari 2013. Deelsessie Smart Energy
Jos Blom Alliander
Jos Blom Alliander
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie Smart Energy
Dennis Meerburg OMALA
Dennis Meerburg OMALA
KennisKring Amsterdam
Slimme Steden, 6 februari 2013. Deelsessie Smart Energy
Marcel Elswijk, Energygo
Marcel Elswijk, Energygo
KennisKring Amsterdam
'Reputatiemanagement, nut en noodzaak van een professionele aanpak' 31-01-2013
31-01-2013 Thierry Thijssen, Coosto
31-01-2013 Thierry Thijssen, Coosto
KennisKring Amsterdam
presentatie Arnold Smeulders, tijdens 'ICT in de metropoolregio Amsterdam: unieke infrastructuur biedt kansen'. 25-06-2012
Arnold Smeulders, directeur COMMIT
Arnold Smeulders, directeur COMMIT
KennisKring Amsterdam
presentatie Job Witteman, tijdens 'ICT in de metropoolregio Amsterdam: unieke infrastructuur biedt kansen'. 26-06-2012
Job Witteman, directeur Amsterdam Internet Exchange
Job Witteman, directeur Amsterdam Internet Exchange
KennisKring Amsterdam
presentatie Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam, tijdens bezoek AH distributiecentrum als deelsessie van 'Dynamiek in Zaanstad als onderdeel van de metropoolregio Amsterdam'
Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam
Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam
KennisKring Amsterdam
Presentatie Sjoerd Soeters tijdens 'Dynamiek in Zaanstad als onderdeel van de metropoolregio Amsterdam' 2012-06-20
Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad
Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad
KennisKring Amsterdam
Afbeeldingen ontwikkelingen Zaanstad, tijdens 'Dynamiek in Zaanstad als onderdeel van de Metropoolregio Amsterdam' 20-06-2012
Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad
Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad
KennisKring Amsterdam
Impact Mobiele Communicatie op Werken en Leven, 29 maart 2012 Door internet en een veelheid aan nieuwsbronnen, neemt de mediaconsumptie alleen maar toe. Echter, de mediaconsument is vandaag misschien wel net zoveel mediaproducent (zie bijv. YouTube). Hoe gaan we om met deze nieuwe verhouding in consumeren, produceren en reageren?
Dick Buschman, oprichter, eigenaar van ACHTUNG!
Dick Buschman, oprichter, eigenaar van ACHTUNG!
KennisKring Amsterdam
Impact Mobiele Communicatie op werken en leven, 29 maart 2012. Door onderzoeken van het Leefritme Kenniscentrum heeft Vodafone inzichten in de sociale en maatschappelijke gevolgen van mobiele communicatie. Ingegaan wordt op de technologische trends die hieraan hebben bijgedragen en het belang voor bedrijven, groot en klein.
Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone
Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone
KennisKring Amsterdam
Presentatie Peter de Groote Lezing, 19 december 2011
Prof. dr. Jouke van Dijk
Prof. dr. Jouke van Dijk
KennisKring Amsterdam
Pieter Hameetman, AM en Lars Falch, NUON. Sprekers bij 'Energietransitie: kansen voor bedrijfsleven en instellingen met Amsterdam Smart City' van 26-10-2011, georganiseerd door KennisKring Amsterdam en partners.
Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011
Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011
KennisKring Amsterdam
Amsterdam Smart City
Amsterdam Smart City
KennisKring Amsterdam
Robert van den Brink, Goudappel Coffeng. Spreker bij ‘Energietransitie: kansen voor bedrijfsleven en instellingen met Amsterdam Smart City’, 26-10-2011, georganiseerd door KennisKring Amsterdam.
Robert van den Brink, Energietransitie, 26-10-2011
Robert van den Brink, Energietransitie, 26-10-2011
KennisKring Amsterdam
Jan de Boer, Dura Vermeer. Spreker bij ‘Energietransitie: kansen voor bedrijfsleven en instellingen met Amsterdam Smart City’, 26-10-2011, georganiseerd door KennisKring Amsterdam.
Jan de Boer, Energietransitie, 26-10-2011
Jan de Boer, Energietransitie, 26-10-2011
KennisKring Amsterdam
Más de KennisKring Amsterdam
(20)
Roel Spits, Poseidon
Roel Spits, Poseidon
Hans Haveman gemeente Enschede
Hans Haveman gemeente Enschede
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
Wilco Schuttelaar, Arjan in 't Veld, We Helpen
Martijn Kriens Amsterdam Economic Board
Martijn Kriens Amsterdam Economic Board
Jos Blom Alliander
Jos Blom Alliander
Dennis Meerburg OMALA
Dennis Meerburg OMALA
Marcel Elswijk, Energygo
Marcel Elswijk, Energygo
31-01-2013 Thierry Thijssen, Coosto
31-01-2013 Thierry Thijssen, Coosto
Arnold Smeulders, directeur COMMIT
Arnold Smeulders, directeur COMMIT
Job Witteman, directeur Amsterdam Internet Exchange
Job Witteman, directeur Amsterdam Internet Exchange
Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam
Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam
Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad
Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad
Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad
Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad
Dick Buschman, oprichter, eigenaar van ACHTUNG!
Dick Buschman, oprichter, eigenaar van ACHTUNG!
Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone
Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone
Prof. dr. Jouke van Dijk
Prof. dr. Jouke van Dijk
Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011
Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011
Amsterdam Smart City
Amsterdam Smart City
Robert van den Brink, Energietransitie, 26-10-2011
Robert van den Brink, Energietransitie, 26-10-2011
Jan de Boer, Energietransitie, 26-10-2011
Jan de Boer, Energietransitie, 26-10-2011
Innovatie in de Sierteelt & het Businessmodel, door Sander de Leeuw, 16 nov 2011
1.
CONSOLIDATIE IN DE
LOGISTIEK
2.
ONTWIKKELINGEN IN LOGISTIEKE
DIENSTEN Top 10 logistieke dienstverleners in Nederland 2006 Top 10 logistieke dienstverleners in Nederland 2011 Bron: www.logistiek.nl
3.
CONSOLIDATIE IN SIERTEELTLOGISTIEK?
Bron: www.logistiek.nl